🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 18 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 28/04/2009 | 22,35 | 22,54 | 21,95 | 22,11 | -1,15% | 2,65% | 24.059.041 |
| 27/04/2009 | 22,33 | 22,61 | 22,15 | 22,37 | -0,04% | 2,05% | 16.986.718 |
| 24/04/2009 | 22,20 | 22,47 | 21,99 | 22,38 | +0,95% | 2,15% | 23.124.749 |
| 23/04/2009 | 22,01 | 22,26 | 21,60 | 22,17 | +1,13% | 2,99% | 37.293.290 |
| 22/04/2009 | 22,33 | 22,42 | 21,31 | 21,92 | -2,42% | 5,00% | 55.546.934 |
| 21/04/2009 | 23,29 | 23,43 | 21,88 | 22,46 | -6,66% | 6,64% | 42.417.590 |
| 20/04/2009 | 24,33 | 24,72 | 24,04 | 24,06 | -1,98% | 2,82% | 13.786.650 |
| 17/04/2009 | 24,71 | 25,28 | 24,47 | 24,55 | -0,46% | 3,28% | 19.709.212 |
| 16/04/2009 | 25,23 | 25,30 | 24,20 | 24,67 | -1,52% | 4,35% | 19.463.980 |
| 15/04/2009 | 24,45 | 25,18 | 24,36 | 25,05 | +2,22% | 3,36% | 16.521.406 |
| 14/04/2009 | 24,72 | 24,98 | 24,40 | 24,50 | -1,42% | 2,35% | 13.162.042 |
| 13/04/2009 | 24,92 | 25,31 | 24,69 | 24,86 | -0,95% | 2,49% | 11.654.494 |
| 09/04/2009 | 26,01 | 26,19 | 24,89 | 25,10 | -1,72% | 5,03% | 15.819.979 |
| 08/04/2009 | 25,17 | 25,53 | 25,01 | 25,53 | +1,87% | 2,09% | 11.073.168 |
| 07/04/2009 | 25,32 | 25,35 | 24,82 | 25,07 | -1,50% | 2,11% | 13.959.779 |
| 06/04/2009 | 25,08 | 26,28 | 25,08 | 25,45 | +0,79% | 4,79% | 13.312.430 |
| 03/04/2009 | 25,76 | 26,06 | 24,90 | 25,25 | -2,00% | 4,52% | 16.227.232 |
| 02/04/2009 | 25,96 | 26,34 | 25,23 | 25,76 | +0,04% | 4,26% | 18.833.608 |
| 01/04/2009 | 25,28 | 25,98 | 24,57 | 25,75 | +0,90% | 5,59% | 18.880.244 |
| 31/03/2009 | 25,58 | 25,84 | 25,31 | 25,52 | +0,75% | 2,09% | 22.948.370 |
| 30/03/2009 | 25,55 | 25,67 | 24,94 | 25,33 | -2,25% | 2,84% | 15.245.256 |
| 27/03/2009 | 25,70 | 26,36 | 25,57 | 25,92 | -1,52% | 3,05% | 17.048.340 |
| 26/03/2009 | 26,50 | 26,54 | 25,84 | 26,32 | +0,29% | 2,63% | 16.516.061 |
| 25/03/2009 | 26,68 | 26,74 | 25,58 | 26,24 | -0,90% | 4,33% | 18.255.950 |
| 24/03/2009 | 26,35 | 26,83 | 26,25 | 26,48 | -0,82% | 2,21% | 15.464.917 |
| 23/03/2009 | 25,95 | 26,70 | 25,54 | 26,70 | +4,72% | 4,45% | 20.397.014 |
| 20/03/2009 | 25,40 | 25,95 | 25,11 | 25,50 | +2,61% | 3,34% | 26.895.977 |
| 19/03/2009 | 25,79 | 25,90 | 24,50 | 24,85 | -3,41% | 5,40% | 25.223.683 |
| 18/03/2009 | 25,10 | 26,24 | 24,93 | 25,73 | +1,32% | 5,21% | 22.185.531 |
| 17/03/2009 | 24,82 | 25,42 | 24,62 | 25,39 | +1,53% | 3,23% | 23.637.326 |